PAVmed PAVM Income Statement (2015-2026)

NASDAQ PAVM
$4.86 +0.14 (+2.97%)
As of: Sep 9, 2026 · 11:09 AM EDT
Reported Financials

PAVmed Quarterly Income Statement

Periods 45 quarters
Latest Jun 2026

PAVmed reported revenue of $0.03M and net income of -$6.60M for the quarter ended Jun 2026, up 312.5% year over year. This income statement covers 45 quarters of results from Mar 2015 through Jun 2026, standardized by Business Quant from the company’s SEC filings.

Income Statement Mar2015 Jun2015 Sep2015 Dec2015 Mar2016 Jun2016 Sep2016 Dec2016 Mar2017 Jun2017 Sep2017 Dec2017 Mar2018 Jun2018 Sep2018 Dec2018 Mar2019 Jun2019 Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Jun2026
Revenue & cost
Revenue
0.20M0.30M0.19M0.08M0.11M0.45M0.17M0.79M1.05M1.01M0.98M0.01M0.01M0.01M0.01M0.08M0.03M
Cost of RevenueCost of Rev
0.14M0.44M0.37M1.63M1.62M1.35M1.69M1.78M1.61M1.74M1.67M0.04M0.05M0.04M0.04M0.06M0.09M0.12M
Gross Profit
0.06M-0.14M-0.18M-1.55M-1.51M-0.90M-1.52M-0.99M-0.56M-0.73M-0.69M-0.04M-0.03M-0.04M-0.05M-0.00M-0.09M
Operating items
Amortization - Intangibles
0.02M0.12M0.12M0.65M0.51M0.51M0.51M0.51M0.51M0.51M0.37M0.10M
Research & DevelopmentR&D
4.26M5.30M6.97M5.93M6.74M6.20M6.67M4.54M4.34M4.02M4.69M4.31M4.24M0.15M0.79M0.79M1.09M1.83M2.07M
Selling, General & AdministrativeSG&A
6.84M6.11M9.11M9.47M11.20M10.37M10.16M10.41M6.65M6.86M7.03M6.68M7.01M4.19M4.38M3.67M3.50M4.69M4.65M
Other Operating ExpensesOther Opex
1.88M2.45M3.90M4.42M5.55M6.87M7.88M1.00M4.06M3.41M0.85M0.28M0.26M0.26M0.33M0.34M
Operating ExpensesOpex
12.97M13.87M19.98M19.82M23.48M23.44M24.71M20.85M16.65M16.32M17.43M15.05M14.66M5.20M5.45M4.72M4.85M6.86M7.05M
Operating IncomeOp. Inc
-12.97M-13.67M-19.68M-19.64M-23.48M-23.37M-24.60M-20.40M-16.48M-15.53M-16.38M-14.04M-13.68M-5.19M-5.45M-4.71M-4.84M-6.80M-7.02M
EBIT
-12.97M-13.67M-19.68M-19.64M-23.48M-23.37M-24.60M-20.40M-16.48M-15.53M-16.38M-14.04M-13.68M-5.19M-5.45M-4.71M-4.84M-6.80M-7.02M
Non-operating items
Non Operating Interest Expenses
0.52M0.53M0.23M0.18M0.23M0.16M0.02M0.02M0.01M0.01M0.03M0.00M0.01M-0.01M0.00M
Non Operating Investment IncomeNon-Op. Investment Inc.
0.12M21.00M-10.64M-4.38M2.50M-2.50M
Interest & Investment IncomeInt & Inv Inc
0.01M0.01M
Other Non Operating IncomeOther Non Op Inc.
0.30M7.43M-7.43M0.00M-5.62M-6.57M0.03M-0.53M-0.74M-1.76M-0.75M-0.37M-0.76M72.29M73.30M0.06M
Non Operating IncomeNon Op. Inc.
-1.81M-1.41M-6.22M-1.02M-4.48M-1.23M6.33M24.07M-7.61M-1.17M4.05M0.42M
Net income details
EBT
-12.67M-13.67M-19.68M-19.63M-29.10M-29.93M-24.57M-22.21M-17.89M-21.75M-17.41M-18.51M-14.91M1.14M18.62M-12.32M-6.01M-2.76M-6.60M
Profit After TaxPAT
-12.67M-13.67M-19.68M-19.63M-29.10M-29.93M-24.57M-22.21M-17.89M-21.75M-17.41M-18.51M-14.91M-14.87M18.97M-12.32M-6.01M-4.13M-6.60M
Income from Non-Controlling InterestsInc. Minority
-1.20M-1.44M-2.46M-2.76M-3.58M-3.81M-4.11M-4.28M-3.35M-4.08M-3.37M-3.30M-4.09M-0.29M-0.34M-0.40M-0.63M-1.49M-1.21M
Income from Continuing OperationsIncome (Continuing)
-12.67M-13.67M-19.68M-19.63M-29.10M-29.93M-24.57M-22.21M-17.89M-21.75M-17.41M-18.51M-14.91M1.14M18.62M-12.32M-6.01M-2.76M-6.60M
Consolidated Net IncomeConsol Net Inc.
-12.67M-13.67M-19.68M-19.63M-29.10M-29.93M-24.57M-22.21M-17.89M-21.75M-17.41M-18.51M-14.91M1.14M18.62M-12.32M-6.01M-2.76M-6.60M
Income towards Parent CompanyParent Net Inc
-12.67M-13.67M-19.68M-19.63M-29.10M-29.93M-24.57M-22.21M-17.89M-21.75M-17.41M-18.51M-14.91M1.14M18.62M-12.32M-6.01M-2.76M-6.60M
Preferred Dividend PaymentsPref Dividends
0.07M0.07M0.07M0.07M0.08M0.08M0.08M0.08M0.09M0.09M0.09M1.52M0.10M
Net Income towards Common StockholdersNet Income
-11.54M-12.29M-17.29M-16.94M-25.59M-26.20M-20.53M-18.00M-14.61M-17.75M-15.90M-22.79M-10.91M-2.03M17.70M-13.31M-6.33M-1.86M-5.48M
Additional items
EPS (Basic)
-2.11-2.21-3.34-2.94-4.41-4.38-3.46-2.78-2.10-2.38-2.20-2.62-1.19-0.211.28-0.74-0.29-2.77-0.87
EPS (Diluted)
-13.35-14.22-19.99-19.59-4.41-4.38-3.46-2.78-2.10-2.38-2.20-2.62-1.19-0.030.34-0.74-0.29-2.77-0.87
Shares Outstanding
5.48M5.55M5.17M5.76M5.80M5.98M5.94M6.47M6.96M7.46M7.23M8.69M9.15M9.15M9.67M13.88M18.08M21.55M0.67M6.27M
Shares Outstanding (Diluted)Shares Outstanding (Dil.)
0.86M0.86M0.86M0.86M5.80M5.98M5.94M6.47M6.96M7.46M7.23M8.69M9.15M9.15M65.29M52.50M18.08M21.55M0.67M6.27M
Shares Outstanding (Entity)Shares Outstanding (Entity.)
5.51M5.63M5.76M5.79M5.80M6.15M6.30M6.71M7.24M19.06M19.06M19.06M19.06M19.06M19.06M20.14M23.05M0.67M23.40M
EBITDA
-12.97M-13.67M-19.68M-19.64M-23.48M-23.37M-24.60M-20.40M-16.48M-15.53M-16.38M-14.04M-13.68M-5.19M-5.45M-4.71M-4.84M-6.80M-7.02M
Interest ExpensesInt Expense
0.52M0.53M0.23M0.18M0.23M0.16M0.02M0.02M0.01M0.01M0.03M0.00M0.01M-0.01M0.00M